Is Ondansetron Augmentation Effective in Obsessive-Compulsive Disorder?

J Clin Psychopharmacol. 2017 Jun;37(3):380-381. doi: 10.1097/JCP.0000000000000704.

Authors

Bangalore G Kalyani¹, Aditya Hegde, Shyam Sundar Arumugham, Janardhanan C Narayanaswamy, Suresh Bada Math, Y C Janardhan Reddy

Affiliation

¹ OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India; North West Area Mental Health Service, Victoria, Australia. adityahegde@outlook.com; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

PMID: 28383360
DOI: 10.1097/JCP.0000000000000704

No abstract available

Publication types

Letter

MeSH terms

Drug Therapy, Combination
Humans
Obsessive-Compulsive Disorder / drug therapy*
Ondansetron / administration & dosage
Ondansetron / pharmacology*
Outcome Assessment, Health Care
Selective Serotonin Reuptake Inhibitors / pharmacology*
Serotonin 5-HT3 Receptor Antagonists / administration & dosage
Serotonin 5-HT3 Receptor Antagonists / pharmacology*

Substances

Serotonin 5-HT3 Receptor Antagonists
Serotonin Uptake Inhibitors
Ondansetron